# Study of AC0058TA in Healthy Male and Female Subjects

> **NCT02847325** · PHASE1 · COMPLETED · sponsor: **ACEA Therapeutics, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AC0058TA
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT02847325
- **Lead sponsor:** ACEA Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847325, "Study of AC0058TA in Healthy Male and Female Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02847325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*